Jump to content
RemedySpot.com

European Parliament Petition - encouraging news!

Rate this topic


Guest guest

Recommended Posts

Guest guest

Thought I’d share with all that I have received a

letter from the European Parliament re our petition. They had a panel

discussion on 27/28 January and have agreed to ask the European Commission to further

research into LDN, continue the examination of Low Dose Nalterexone and as soon

as they reach a decision they will write back to me.

The door hasn’t been slammed in our faces, so please

folks, continue to support the LDN petition to the European Parliament –

it really is important and don’t forget, don’t fund the petition

link. All that’s needed is your signature and support. This

really is of vital international importance and anyone can sign anywhere in the

world. Please click here http://www.ipetitions.com/petition/ldnnow/

I can’t stress the importance of this. Please

cross reference to other groups as you see fit. Appreciate this.

Many thanks!

Jayne Crocker

www.LDNNow.com

Important! Please sign our LDN petition to the

European Parliament by clicking here

tel: +44 (0) 7877 492 669

Dr Steele MBE, talking about LDN

LDNNow, a patient and friend led organisation (so not a charity)

with no funding and no affiliation to any company or organisation, but rather a

group of concerned individuals focussed on improving the health of those who

suffer from the many diseases and conditions that LDN treats.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...